Alzheimer's Association International Conference

July 16–20 Annual Conference
July 14–15 Preconferences

Priavoid at AAIC 2017

The Priavoid spin off project has been presented at the Alzheimer’s Association International Conference 2017 in London (16th to 20th of July). We have been at the booth of the Jülich Research Center (Number 119).

Prof. Dr. Dieter Willbold presented the preclinical results of Priavoids AD drug candidate on the 17th of July at 4:15 pm (session O2-14, Preclinical): “Aβ Oligomer Eliminating D-Enantiomeric Peptides Enhance Cognition and Impede Neurodegeneration Even By Oral Application”


More Information


Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help.

Select an option to continue

Your selection was saved!



To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set.

You can change your cookie setting here anytime: Privacy Policy. Legal Notice